Agios Pharmaceuticals | AGIO - Cost Of Sales


Agios Pharmaceuticals reported $1.88M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
AbbVie USD 4.55B 757M Dec/2025
Agios Pharmaceuticals USD 1.88M 199K Dec/2025
Alnylam Pharmaceuticals USD 267.72M 67.57M Dec/2025
Amgen USD 1.79B 128M Dec/2025
Astellas Pharma JPY 149.13B 10.88B Dec/2025
AstraZeneca USD 3.27B 471M Dec/2025
Bayer EUR 4.5B 194M Dec/2025
Biogen USD 810.1M 205.1M Sep/2025
BioMarin Pharmaceutical USD 161.56M 16.62M Dec/2025
Bristol-Myers Squibb USD 4.92B 657M Dec/2025
Daiichi Sankyo JPY 118.28B 37.7B Dec/2025
Eli Lilly USD 3.37B 363.7M Dec/2025
Exelixis USD 26.48M 7.91M Dec/2025
Gilead Sciences USD 1.62B 50M Dec/2025
GlaxoSmithKline GBP 2.61B 377M Dec/2025
Incyte USD 121.18M 22.18M Dec/2025
Ionis Pharmaceuticals USD 8M 5.66M Dec/2025
Merck USD 3.32B 531M Dec/2025
Moderna USD 452M 245M Dec/2025
Nektar Therapeutics USD 4.43M 5.3M Sep/2024
Novartis USD 3.54B 3M Dec/2025
Novartis USD 3.54B 7M Dec/2025
Pfizer USD 6.29B 2.12B Dec/2025
Puma Biotechnology USD 29.1M 18.44M Sep/2024
Regeneron Pharmaceuticals USD 584.6M 63M Dec/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
Sarepta Therapeutics USD 399.38M 247.93M Dec/2025
Vertex Pharmaceuticals USD 466M 51.2M Dec/2025